Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 3/20 | 0.33 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.32 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.31 |
| ▸ | ACVR1 | Q04771 | 2/20 | 0.31 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.31 |
| ▸ | GRM5 | P41594 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17381580 | 0.93 | NR1H4 (0.34) | ABL1GPR119SSTR2GRM5 | |
| SCHEMBL30681665 | 0.89 | NR1H4 (0.34) | ABL1GPR119SSTR2GRM5 | |
| SCHEMBL17381571 | 0.89 | NR1H4 (0.34) | ABL1GPR119SSTR2GRM5 | |
| SCHEMBL31236971 | 0.88 | MKNK1 (0.31) | TGFBR1ACVR1 | |
| SCHEMBL27119775 | 0.88 | PDE7A (0.36) | ABL1GPR119SSTR2GRM5CYP11B1 | |
| SCHEMBL30759597 | 0.88 | PDE7A (0.36) | ABL1GPR119SSTR2GRM5CYP11B1 | |
| SCHEMBL27118975 | 0.87 | PDE7A (0.35) | ABL1GPR119SSTR2GRM5CYP11B1 | |
| SCHEMBL30759484 | 0.87 | PDE7A (0.35) | ABL1GPR119SSTR2GRM5CYP11B1 | |
| SCHEMBL23072074 | 0.85 | GPR119 (0.32) | ABL1GPR119CYP11B2 | |
| SCHEMBL17381595 | 0.85 | PTGDR2 (0.35) | GRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024263803-A2 | NOVEL MODULATORS OF FSHR AND USES THEREOF | CELMATIX INC. (US) | 2024-12-26 | — | — | WO | disclosed |